ApiJect Awarded Grant to Develop Low-Cost Prefilled Injectors

Aims to make the safety and performance advantages of single-use prefilled syringes affordable and available for more patients.

Author Image

By: Charlie Sternberg

Associate Editor

ApiJect Systems Corp., a public-benefit medical technology company whose device development platform aims to make the safety and performance advantages of single-use prefilled syringes affordable and available for more patients, has been awarded an initial grant of $425,000 from the Bill & Melinda Gates Foundation.   The funding will support the design and development of low-cost Prefilled ApiJect Injectors for injectable medicines and vaccines, with a focus on use in LMICs.   “We are ho...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters